13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q4 2017. See the latest, Q3 2026 →

Reported value

$1.98B

−9.8% on the quarter before

Positions

30

16 new, 23 sold out

Top 10

73.7%

of the value

Est. gain

+$149.0M

on stocks held all quarter

Est. return

+12.4%

on those stocks since Q3 2017

Filed

Feb 14, 2018

On SEC EDGAR ↗

Positions as of Dec 31, 2017, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.

Microsoft14%Alphabet14%Amazon9.9%Meta9.6%Salesforce8.8%
Nektar Therapeutics5.5%
Workday4.3%
6 others4.0%
Eog Res Inc2.9%
Wells Fargo Co New2.6%
Bank Amer Corp2.6%
Jd Com Inc2.3%
Devon Energy Corp New2.1%
Apache Corp1.9%
Biogen Inc1.8%
PayPal1.7%
Ctrip Com Intl Ltd1.6%
Stamps Com Inc1.6%
Concho Res Inc1.6%
Ac Immune Sa1.5%
Cabot Oil & Gas Corp1.5%
Time Warner Inc1.3%
United States Stl Corp New1.3%
Marathon Pete Corp1.1%
Andeavor1.0%

Largest buys

Since Q3 2017, sized at quarter-end prices.

  1. Eog Res Inc~$56.6MNew, 0.0% → 2.9% of the portfolio+524,700 shares
  2. Wells Fargo Co New~$51.6MNew, 0.0% → 2.6% of the portfolio+850,000 shares
  3. Bank Amer Corp~$50.7MNew, 0.0% → 2.6% of the portfolio+1,717,500 shares
  4. Devon Energy Corp New~$41.8MNew, 0.0% → 2.1% of the portfolio+1,009,800 shares
  5. Nektar Therapeutics~$39.9MAdded, 1.3% → 5.5% of the portfolio+667,900 shares
  6. Apache Corp~$38.1MNew, 0.0% → 1.9% of the portfolio+903,000 shares
  7. Stamps Com Inc~$31.6MNew, 0.0% → 1.6% of the portfolio+168,000 shares
  8. Concho Res Inc~$31.0MNew, 0.0% → 1.6% of the portfolio+206,400 shares
  9. Cabot Oil & Gas Corp~$29.8MNew, 0.0% → 1.5% of the portfolio+1,040,200 shares
  10. Microsoft~$27.5MAdded, 9.8% → 13.9% of the portfolio+321,700 shares

Largest sells

Since Q3 2017, sized at quarter-end prices.

  1. Priceline Grp Inc~$135.6MSold out, 6.2% → 0.0% of the portfolio−74,090 shares
  2. Alibaba~$134.3MSold out, 6.1% → 0.0% of the portfolio−777,400 shares
  3. Electronic Arts Inc~$84.3MSold out, 3.8% → 0.0% of the portfolio−713,900 shares
  4. Citigroup Inc~$79.7MSold out, 3.6% → 0.0% of the portfolio−1,095,200 shares
  5. Expedia Inc Del~$46.6MSold out, 2.1% → 0.0% of the portfolio−323,884 shares
  6. Activision Blizzard Inc~$46.1MSold out, 2.1% → 0.0% of the portfolio−714,100 shares
  7. Jd Com Inc~$45.0MCut, 3.8% → 2.3% of the portfolio−1,086,900 shares
  8. Las Vegas Sands Corp~$39.4MSold out, 1.8% → 0.0% of the portfolio−614,500 shares
  9. Ishares Tr~$36.9MSold out, 1.7% → 0.0% of the portfolio−110,700 shares
  10. PayPal~$33.9MCut, 2.7% → 1.7% of the portfolio−460,100 shares

Holdings

As of Dec 31, 2017; changes in shares since Sep 30, 2017.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares +11% · price +14.8%13.9%$276.1M+$32.1M
AlphabetCAP STK CL A · shares +11% · price +8.2%13.7%$271.1M+$18.5M
AmazonCOM · shares +15% · price +21.6%9.9%$196.5M+$30.3M
MetaCL A · shares −0.1% · price +3.3%9.6%$191.0M+$6.0M
SalesforceCOM · shares +12% · price +9.4%8.8%$175.3M+$13.4M
Nektar TherapeuticsCOM · shares +57% · price +148.8%5.5%$109.5M+$41.7M
WorkdayCL A · shares +6.0% · price −3.5%4.3%$84.7M−$2.9M
Eog Res IncCOM · shares New2.9%$56.6M—
Wells Fargo Co NewCOM · shares New2.6%$51.6M—
Bank Amer CorpCOM · shares New2.6%$50.7M—
Jd Com IncSPON ADR CL A · shares −50% · price +8.4%2.3%$45.5M+$3.5M
Devon Energy Corp NewCOM · shares New2.1%$41.8M—
Apache CorpCOM · shares New1.9%$38.1M—
Biogen IncCOM · shares +128% · price +1.7%1.8%$34.9M+$261,554
PayPalCOM · shares −50% · price +15.0%1.7%$34.2M+$4.5M
Ctrip Com Intl LtdAMERICAN DEP SHS · shares −48% · price −16.4%1.6%$32.1M−$6.3M
Stamps Com IncCOM NEW · shares New1.6%$31.6M—
Concho Res IncCOM · shares New1.6%$31.0M—
Ac Immune SaSHS · shares 0% · price +13.3%1.5%$30.6M+$3.6M
Cabot Oil & Gas CorpCOM · shares New1.5%$29.8M—
Time Warner IncCOM NEW · shares New1.3%$25.4M—
United States Stl Corp NewCOM · shares New1.3%$25.0M—
Marathon Pete CorpCOM · shares New1.1%$21.2M—
AndeavorCOM · shares New1.0%$20.8M—
Marathon Oil CorpCOM · shares New1.0%$20.8M—
Total 30 positions100%$1.98B+$149.0M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2017 to Q4 2017: 14 stocks held throughout, up $149.0M (+12.4%).

  1. Nektar Therapeutics+$41.7M+149%
  2. Microsoft+$32.1M+15%
  3. Amazon+$30.3M+22%
  4. Alphabet+$18.5M+8%
  5. Salesforce+$13.4M+9%
  6. Workday−$2.9M−3%
  7. Ctrip Com Intl Ltd−$6.3M−16%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free